antibiotic drugs to prevent this morbidity is anticipated to augment market demand over the forecast period.
Increasing number of cases related to other infectious diseases such as HIV, pneumonia, malaria, and
tuberculosis is further propelling market growth since last couple of decades.
Moreover, surfacing of unfamiliar infections, such as Zika virus and Ebola, has led to the soaring demand of
antibiotics in the market. Recent collaborations among various private bodies and research institute with
governmental agencies and colleges to develop innovative techniques and products to fight against unfamiliar
infections, such as Zika virus and Ebola is predicted to fuel market growth over the forecast period.
Rising funding from regional governments for innovative R&D approaches is leading to the generation of new
pipeline products. However, complexity associated with development of advanced antibiotics and high initial
cost are some of the major restraining factors for market growth to a certain extent. Additionally, lack of
awareness of these products in underdeveloped economies and the high cost of development of the drugs is
anticipated to limit market growth.
The monoclonal antibodies is considered as one of the fastest growing segment in the antibiotics market with
substantial revenue generation in the last couple of years. Other market segment along with monoclonal
antibodies such as tetracyclines, imidazoles and lincosamides hold massive market share across the globe.
Numerous benefits of monoclonal antibodies over its counter parts is considered as major driving factor for the
growth of monoclonal antibodies market segment. Growing prevalence of pneumonia, blood stream infections,
and urinary tract infections (UTI) are predicted to boost the demand of carbapenems class of antibiotics.
The antibiotics market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa.
Latin America has shown major growth in recent years owing to the rise in the implementation of latest
technologies in pharmaceuticals & medicine sector, strong economic growth in the region, and existence of
well-established healthcare infrastructure.
Asia-Pacific region is predicted to hold major market share in the antibiotics market with massive growth in
forecast period. Countries such as India, China and Japan are leading the Asia-Pacific’s market with increasing
occurrence of infectious diseases, ever-growing population in developing economies, favorable governmental
regulation and reforms, increasing use of generic medicines, and significant investment by leading industry
players considering potential growth opportunities in the region.
The key players in the antibiotics market are Pfizer Incorporations, Janssen Pharmaceuticals, Inc., Abbott
Laboratories, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly
and Company Co., and Astellas Pharma Incorporations.
Browse Related Category Market Reports @
https://www.millioninsights.com/industry/pharmaceuticals